Oral PRI-002 treatment in patients with MCI or mild AD: a randomized, double-blind phase 1b trial

Journal:

Nature Communications

Published:

2025-05-06

DOI:

10.1038/s41467-025-59295-z

Affiliations:

5

Authors:

10

Go to article

Institutions	Authors	Share
Institute of Biological Information Processing (IBI), FZJ, Germany	3.500000	0.35
Charité - University Medicine Berlin, Germany	3.500000	0.35
attyloid GmbH, Germany	2.000000	0.20
Berlin Institute of Health (BIH), Germany	0.500000	0.05
Heinrich Heine University Düsseldorf (HHU), Germany	0.500000	0.05

Interested in Neurosciences?